BCCI set to earn over Rs 2000-cr from IPL

New Delhi, Feb 27: Congress leader Priyanka Gandhi Vadra on Thursday attacked the government over the transfer of Delhi High Court Judge S Muralidhar, saying the Centre's attempts to "muzzle" justice and "break people's faith in an upright judiciary are deplorable".

Delhi HC Judge S Muralidhar was transferred to the Punjab and Haryana High Court, days after the Supreme Court collegium made the recommendation.

"The midnight transfer of Justice Muralidhar isn't shocking given the current dispensation, but it is certainly sad & shameful," Priyanka Gandhi tweeted. "Millions of Indians have faith in a resilient & upright judiciary, the government’s attempts to muzzle justice & break their faith are deplorable," she said.

The judge was hearing the Delhi violence case and the late evening notification came on the day when a bench headed by him expressed "anguish" over the Delhi Police's failure to register FIRs against alleged hate speeches by three BJP leaders.

Beijing/Zurich, Mar 4: China has approved the use of Swiss drugmaker Roche's anti-inflammation drug Actemra for patients who develop severe complications from the coronavirus as it urgently hunts for new ways to combat the deadly infection that is spreading worldwide.

China is hoping that some older drugs could stop severe cytokine release syndrome (CRS), or cytokine storms, an overreaction of the immune system which is considered a major factor behind catastrophic organ failure and death in some coronavirus patients.

Actemra, a biologic drug approved in 2010 in the United States for rheumatoid arthritis (RA), inhibits high Interleukin 6 (IL-6) protein levels that drive some inflammatory diseases.

China's National Health Commission said in treatment guidelines published online on Wednesday that Actemra can now be used to treat coronavirus patients with serious lung damage and high IL-6 levels.

Separately, researchers in the country are testing Actemra, known generically as tocilizumab, in a clinical trial expected to include 188 coronavirus patients and running until May 10.

Roche, which donated 14 million yuan ($2.02 million) worth of Actemra during February, said the trial was initiated independently by a third party with the aim of exploring the efficacy and safety of the drug in coronavirus patients with CRS.

It added that there was currently no published clinical trial data on the drug's safety or efficacy against the virus.

More than 3,000 people have died and 93,000 have been infected by the novel coronavirus thought to have originated in Wuhan, China, before spreading to around 90 countries including the United States, Italy, Switzerland, France and Germany.

The Swiss company, for which China is its No. 2 market behind the United States, also makes diagnostic gear to detect the coronavirus.

Since Actemra's approval a decade ago, it has become a go-to drug against other inflammatory conditions, including cytokine storms in cancer patients receiving cell therapies from Novartis and Gilead Sciences.

In 2012 it helped save the life of a young U.S. girl, the first child to be treated for leukaemia with Novatis' Kymriah, from a post-treatment rush of IL-6.

Priced at between $20-30,000 annually for RA according to SSR Health, Roche's medicine is also used for rare juvenile arthritis and giant cell arteritis, or inflammation of the blood vessels.

Jun 18: Sri Lanka "sold" the 2011 World Cup final to India, the country's former sports minister said on Thursday, reviving one of cricket's most explosive match-fixing controversies. Mahindananda Aluthgamage, who was sports minister at the time, is the second senior figure to allege the final was fixed, after 1996 World Cup-winning skipper Arjuna Ranatunga. "I tell you today that we sold the 2011 World Cup finals," Aluthgamage told Sirasa TV. "Even when I was sports minister I believed this."

Aluthgamage, sports minister from 2010 to 2015 and now state minister for renewable energy and power, said he "did not want to disclose" the plot at the time.

"In 2011, we were to win, but we sold the match. I feel I can talk about it now. I am not connecting players, but some sections were involved," he said.

Sri Lanka lost the match at Mumbai's Wankhede stadium by six wickets. Indian players have strongly denied any wrongdoing.

Ranatunga, who was at the stadium as a commentator, has previously called for an investigation into the defeat.

"When we lost, I was distressed and I had a doubt," he said in July 2017. "We must investigate what happened to Sri Lanka at the 2011 World Cup final."

"I cannot reveal everything now, but one day I will. There must be an inquiry," added Ranatunga, who said players could not hide the "dirt".

Sri Lanka batted first and scored 274-6 off 50 overs. They appeared in a commanding position when Indian superstar Sachin Tendulkar was out for 18.

But India turned the game dramatically, thanks partly to poor fielding and bowling by Sri Lanka, who were led by Kumar Sangakkara.

Sri Lankan cricket has regularly been involved in corruption controversies, including claims of match-fixing ahead of a 2018 Test against England.

Earlier this month, the Sri Lankan cricket board said the International Cricket Council was investigating three unnamed former players over alleged corruption.

Sri Lanka introduced tough penalties for match-fixing and tightened sports betting restrictions in November in a bid to stamp out graft.

Another former sports minister, Harin Fernando, has said Sri Lankan cricket was riddled with graft "from top to bottom", and that the ICC considered Sri Lanka one of the world's most corrupt nations.

Former Sri Lankan fast bowler Dilhara Lokuhettige was suspended in 2018 for corruption relating to a limited-overs league.

He was the third Sri Lankan charged under the ICC anti-corruption code, following former captain and ex-chief selector Sanath Jayasuriya, and former paceman Nuwan Zoysa.

Jayasuriya was found guilty of failing to cooperate with a match-fixing probe and banned for two years. Zoysa was suspended for match-fixing.